MeSH term
Frequency | Condition_Probility | Animals | 12 | 0.0 |
Blotting, Western | 2 | 0.0 |
Cyclic AMP/*metabolism | 3 | 1.0 |
DNA-Binding Protein, Cyclic AMP-Responsive/*metabolism | 5 | 6.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Enzyme Inhibitors/pharmacology | 3 | 0.0 |
Humans | 40 | 0.0 |
JNK Mitogen-Activated Protein Kinases | 2 | 0.0 |
Mice | 3 | 0.0 |
Mitogen-Activated Protein Kinases/*metabolism | 2 | 0.0 |
Phosphorylation | 13 | 0.0 |
Protein Binding | 4 | 0.0 |
Research Support, Non-U.S. Gov't | 30 | 0.0 |
Signal Transduction | 6 | 0.0 |
Transcription Factors/metabolism | 9 | 0.0 |
Transcription, Genetic | 8 | 0.0 |
p38 Mitogen-Activated Protein Kinases | 3 | 0.0 |
Adult | 4 | 0.0 |
Chromosomes, Human, Pair 12 | 3 | 1.0 |
Chromosomes, Human, Pair 22 | 5 | 3.0 |
*DNA-Binding Proteins | 10 | 0.0 |
Female | 6 | 0.0 |
Gene Expression | 2 | 0.0 |
Neuroblastoma/genetics | 2 | 8.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 5 | 0.0 |
Sarcoma, Ewing's/genetics | 2 | 18.0 |
Transcription Factors/genetics | 2 | 0.0 |
Translocation, Genetic | 7 | 0.0 |
Tumor Cells, Cultured | 8 | 0.0 |
Adolescent | 3 | 0.0 |
Base Sequence | 18 | 0.0 |
Cloning, Molecular | 6 | 0.0 |
DNA Mutational Analysis | 2 | 0.0 |
Male | 7 | 0.0 |
Middle Aged | 3 | 0.0 |
Molecular Sequence Data | 23 | 0.0 |
DNA Primers | 3 | 0.0 |
DNA-Binding Proteins/*genetics | 3 | 0.0 |
Oncogene Proteins, Fusion/*genetics | 2 | 1.0 |
Research Support, U.S. Gov't, P.H.S. | 17 | 0.0 |
DNA-Binding Proteins/metabolism | 3 | 0.0 |
Models, Genetic | 2 | 0.0 |
Mutation | 5 | 0.0 |
Phenotype | 2 | 0.0 |
Plasmids/metabolism | 2 | 0.0 |
Promoter Regions (Genetics) | 7 | 0.0 |
Cell Line | 5 | 0.0 |
DNA-Binding Protein, Cyclic AMP-Responsive/metabolism | 4 | 3.0 |
Genes, Reporter | 6 | 0.0 |
Hela Cells | 15 | 0.0 |
Plasmids | 3 | 0.0 |
Transcription Factors/*metabolism | 6 | 0.0 |
*Transcription, Genetic | 3 | 0.0 |
Transfection | 12 | 0.0 |
Amino Acid Sequence | 16 | 0.0 |
DNA, Neoplasm | 2 | 1.0 |
*Repressor Proteins | 3 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Promoter Regions (Genetics)/genetics | 2 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Trans-Activation (Genetics) | 4 | 0.0 |
Transcription Factors/genetics/*metabolism | 2 | 0.0 |
Adenoviridae/*genetics | 2 | 0.0 |
Rats | 3 | 0.0 |
Transcription Factors/*physiology | 3 | 0.0 |
Transcription Factors/*genetics/metabolism | 2 | 0.0 |
Phosphorylation/drug effects | 2 | 0.0 |
Tetradecanoylphorbol Acetate/pharmacology | 4 | 0.0 |
Binding Sites | 4 | 0.0 |
Cell Nucleus/metabolism | 4 | 0.0 |
DNA-Binding Proteins/*metabolism | 3 | 0.0 |
Kinetics | 2 | 0.0 |
*Promoter Regions (Genetics) | 5 | 0.0 |
*Trans-Activation (Genetics) | 3 | 0.0 |
Apoptosis | 2 | 0.0 |
Cell Survival | 2 | 0.0 |
DNA-Binding Proteins/immunology/*metabolism | 2 | 8.0 |
Epitopes | 2 | 0.0 |
Flow Cytometry | 2 | 0.0 |
Immunoglobulin Fragments/metabolism | 2 | 25.0 |
In Situ Nick-End Labeling | 2 | 0.0 |
Oncogene Proteins, Fusion/immunology/*metabolism | 2 | 100.0 |
Retroviridae | 2 | 2.0 |
Sarcoma, Clear Cell/*metabolism/pathology | 2 | 100.0 |
Time Factors | 2 | 0.0 |
Blotting, Northern | 2 | 0.0 |
COS Cells | 3 | 0.0 |
Leucine Zippers | 5 | 3.0 |
Sequence Alignment | 3 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Sequence Homology, Amino Acid | 8 | 0.0 |
Comparative Study | 2 | 0.0 |
Enzyme Activation | 3 | 0.0 |
Gene Expression Regulation, Enzymologic | 2 | 0.0 |
*Immediate-Early Proteins | 2 | 0.0 |
*Mitogen-Activated Protein Kinases | 4 | 1.0 |
Protein-Serine-Threonine Kinases/*metabolism | 2 | 0.0 |
Transcription Factors/*genetics | 2 | 0.0 |
Cell Line, Tumor | 3 | 0.0 |
*Translocation, Genetic | 2 | 0.0 |
Casein Kinase II | 2 | 1.0 |
In Vitro | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Cyclic AMP-Dependent Protein Kinases/metabolism | 2 | 1.0 |
Dimerization | 2 | 0.0 |
*Mitogen-Activated Protein Kinase Kinases | 2 | 2.0 |
Schizosaccharomyces/*genetics | 2 | 5.0 |
*Schizosaccharomyces pombe Proteins | 2 | 2.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
*Gene Expression Regulation | 3 | 0.0 |
Mutagenesis, Site-Directed | 4 | 0.0 |
Transcription Factors/chemistry/*metabolism | 2 | 1.0 |
Recombinant Fusion Proteins/biosynthesis | 2 | 0.0 |
Recombinant Proteins | 2 | 0.0 |
DNA-Binding Proteins/genetics/metabolism | 3 | 0.0 |
Fungal Proteins/genetics | 2 | 1.0 |
DNA/*metabolism | 3 | 0.0 |
Structure-Activity Relationship | 2 | 0.0 |
Heterogeneous-Nuclear Ribonucleoproteins | 2 | 1.0 |
Nuclear Proteins/*genetics | 2 | 0.0 |
RNA-Binding Protein EWS | 2 | 7.0 |
RNA-Binding Proteins/*genetics | 2 | 1.0 |
Ribonucleoproteins/*genetics | 2 | 4.0 |
Open Reading Frames | 2 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
Restriction Mapping | 2 | 0.0 |
DNA/metabolism | 2 | 0.0 |
Protein Kinases/metabolism | 2 | 0.0 |
DNA-Binding Protein, Cyclic AMP-Responsive | 2 | 8.0 |
Gene Expression Regulation/*physiology | 2 | 0.0 |
